Choose LifeCanvas’s sample-to-dataset tissue processing services to get more insight into your research questions than ever before! Our comprehensive and flexible pipeline covers tissue preservation, delipidation, immunolabeling, imaging, and analysis of whole organs, completely replacing the laborious, destructive, and error-prone process of passive, thin-section histology. Take advantage of our technology and methods to:
• Reduce time and resources needed to process large tissue samples at high throughput.
• Avoid lost information from destructive sectioning or alignment errors.
• View anatomical features at high resolution in multiple planes.
• Visualize complete, whole-organ datasets that provide greater context for analysis and novel discoveries, avoiding spotlight and confirmation biases.
• Align datasets to finely detailed reference atlases, allowing for accurate and reproducible quantitative analysis.
To learn more about the advantages of whole-sample analysis, please read our blog post “Why use intact samples for your research?”
We are happy to offer a Pilot Study Discount for eligible new customers to evaluate our services! Fill out the form linked below and tell us about your tissue and target interests and research goals.
*Offer limited to certain services and applications.
Delipidating tissue to enable intact-sample labeling and imaging involves exposing samples to harsh treatments like high temperatures and pH changes. If left unchecked, this can cause damage to proteins and overall tissue structure, leading to incomplete or inaccurate image datasets. Therefore, to preserve the sample’s endogenous fluorescence and antigenicity along with tissue architecture, we use a novel tissue preservation technique called SHIELD that forms intramolecular bonds using polyfunctional, flexible epoxides to stabilize tissue architecture.
After SHIELD preservation, the tissue can be delipidated and either refractive index (RI)-matched for imaging or subjected to active immunohistochemical labeling. Notably, SHIELD-preserved tissues are well-suited for antibody multiplexing, i.e., iterative staining and de-staining, without loss of tissue antigenicity, to build up a rich picture of protein expression over repeated rounds of imaging.
Eliminating membrane lipids is crucial to enabling better light penetration for imaging and increasing tissue permeability for active transport of molecular probes deep into intact tissue. Our active clearing device, SmartClear II Pro, employs a patent-pending stochastic electrotransport mechanism to foster rapid delivery of exogenous molecules such as the detergent SDS into tissues, facilitating uniform removal of light-scattering membrane lipids. Thanks to the application of a rotational electric field which minimizes the displacement of structural biomolecules, the tissue is cleared without any damage or deformation.
Attempting to passively immunolabel samples that are a few millimeters to one centimeter thick usually takes many weeks and very high concentrations of expensive antibodies, without any guarantee that staining will extend to the sample’s innermost structures.
Our SmartLabel device combines two technologies – stochastic electrotransport and SWITCH – and allows us to achieve whole-organ antibody staining that is uniform from surface to core. While stochastic electrotransport provides for efficient distribution of antibodies into the organ, SWITCH controls reaction kinetics to ensure that antibody binding isn’t activated until reagent concentration has been homogenized throughout the sample. The result is strikingly uniform labeling that enables you to visualize proteins deep within the organ and study the fine-scale topography of the cells they identify.
Acquiring high resolution, three-dimensional volumetric image data of whole organs using confocal or two-photon microscopy is a time-consuming and expensive process, as these slow line-scanning techniques are best suited to small, localized regions of interest. Light-sheet microscopy overcomes this speed limitation by selectively illuminating distinct focal planes sequentially from the sides of the tissue sample to achieve optical sectioning. LifeCanvas’s own light-sheet microscope, SmartSPIM, offers superior imaging speed and uniform axial resolution across the entire sample, generating datasets with pixels sized 1.8 µm/px in XY and with 4 µm Z-steps (3.6x, 0.2 NA objective; ~4.5 µm tall PSF). With rapid 4-color acquisition (488, 561, 642, & 785 laser lines) of your embedded samples, we can precisely overlay multiplexed immunofluorescence signals and fluorescent protein expression patterns alike.
Ultimately, some level of quantitative data analysis may be necessary to obtain true biological insights. However, analysis of fully intact, whole organ datasets requires advanced algorithms to align three-dimensional image volumes to standardized organ atlases (such as the Allen Brain Atlas), followed by object quantification (such as fluorescence intensity quantification or cell counts) within aligned and segmented regions. LifeCanvas Technologies is pioneering these and other quantitative data analysis measures for 3D volumetric datasets.
Mouse brain hemisphere with large tumor in the striatum.
Nuclear stain (SYTO16, in cyan) and vasculature stain (DyLight 649-conjugated tomato lectin, in pink) made possible in <1 day by SmartLabel. Sample courtesy of Translational Bioimaging Group @ Barrow Neurological Institute.
Intact tissue clearing combined with whole sample imaging and analysis can provide insights into previously inaccessible levels of biological detail and understanding.
LifeCanvas Technologies offers the tools and technologies to enable access to these insights:
SmartClear II Pro – Tissue clearing instrument capable of processing up to four adult mouse brains or eight hemispheres simultaneously, fully clearing in 3-5 days.
SmartLabel – Advanced immunostaining device, capable of uniformly labeling fully intact, several millimeter-thick tissues with multiple probes in under 24 hours.
SmartSPIM – Light sheet microscope optimized for resolution, speed, and flexibility for imaging large samples. High resolution, single channel imaging of an intact adult mouse brain can be achieved in 60 minutes or less.
Advanced 3D image analysis – Full service options including mouse brain atlas alignment, regional segmentation, fluorescence intensity measurements, and cell counting.
Growing evidence suggests that certain psychiatric diseases such as schizophrenia and developmental disorders such as autism may involve subtle changes in specific neuronal cell-types. GABAergic interneurons that express the calcium-binding protein parvalbumin (PV) are one such cell-type, with PV-cells comprising about ~50% of all GABAergic interneurons and therefore being ~1 out of every 10 neurons in the brain. How does the number and distribution of PV-cells throughout the brains of mouse models of these disorders differ as a function of disease state? To address this question in the most unbiased manner, eFLASH whole hemisphere or whole brain labeling can be performed using LifeCanvas Technologies’ SmartLabel rapid immunohistochemistry device. Following SHIELD tissue preservation and optical clearing via delipidation in SmartClear II Pro, this intact mouse brain hemisphere was immunolabeled in only ~24 hours using just 20 µg of anti-PV antibody.
By refractive index matching the hemisphere and then imaging it in just ~30 minutes using LifeCanvas’s SmartSPIM light-sheet microscope, single-cell resolution data of the entire sample is acquired in one contiguous image volume, enabling holistic analysis of the tissue. Compared to cutting tissue into hundreds of thin sections and then imaging only those discrete regions of interest (ROIs) thought important to interrogate a specific hypothesis, unbiased study of the whole organ helps counteract spotlight biases and creates fertile ground where novel and unexpected discoveries can take place. By co-staining for additional cell-type markers and then analyzing the image data by aligning it to a reference atlas and quantifying number of PV-positive cells per brain region with automated cell-detection algorithms, a powerful pipeline to molecularly phenotype tissues can be created. With this approach, new insight into mouse models of these disorders could be obtained by investigating potential changes in the density and laminar & regional patterning of these cells, as well as changes in their co-expression of markers of neuronal activation (e.g., immediate early genes) or cell health (e.g., oxidative stress markers). Importantly, by performing these analyses and assessing the effects of candidate pharmacological interventions aimed at treating these conditions on a brain-wide basis, a much more complete picture than can be obtained from using only thin sections of tissue can be considered.
Xenograft models have been an essential research tool for neuro-oncology researchers. The establishment of orthotopic xenograft brain tumors requires the injection of tumor cells into relevant neuro-anatomical sites. Monitoring the spatial distribution and growth of intracranially-implanted tumors requires non-invasive live-imaging methods such as positron emission tomography (PET). Here, to assist researchers at the Barrow Neurological Institute validate a novel application of a PET tracer, LifeCanvas scientists preserved, cleared, labeled, and imaged at single-cell resolution mouse brain hemispheres that harbored xenografted striatal tumors. SYTO16 (cyan) was used as a nuclear stain and DyLight 649-conjugated tomato lectin (magenta) as a vascular stain, which together highlight the tumor’s morphology.
Had researchers at the Barrow Neurological Institute not tried LifeCanvas’s state-of-the-art tissue processing pipeline and instead used conventional histological methods it would have been a far more labor-intensive and time-consuming process, only to produce an image dataset that cannot be used as flexibly as the one generated by LifeCanvas. Specifically, our volumetric imaging capabilities enabled the researchers to easily and precisely visualize their orthotopic tumors in 3D and from whichever anatomical plane they desired, providing unparalleled insight into the extent of the tumor and its effects on the brain tissue.
Furthermore, our technologies can be broadly applied to tumor tissue from various models of cancer, including cell-line based and patient-derived xenografts. As cancer researchers increasingly shift towards more complex and pathologically-relevant model systems, it is critical that methods for extracting biological information can visualize and quantify molecular and structural information in 3D and at single-cell resolution. Our SHIELD tissue preservation strategies enable multiple rounds of immunolabeling, helping capture nuanced biological information that is only accessible from highly-multiplexed studies. For example, one could imagine using our tissue clearing and imaging pipeline to characterize local invasion and distant bone or brain metastases in animal models of breast cancer, staining for the requisite markers along the way. One could additionally assess how specific drug treatments simultaneously affect the immunological landscape and matrix composition of the tumor microenvironment, overlaying each new round of data in turn and building up a rich, holistic picture of the tissue.
LifeCanvas is the only company with the tools and capabilities necessary to achieve this unprecedented advance in tissue phenotyping, with our expertise available to customers both of our devices and of our Contract Research Services arm. By working with us, the possibilities are endless.
Perhaps more than any other area of the nervous system, applying tissue clearing and large format imaging techniques to the spinal cord offers researchers an unparalleled view into both its fine-scale cellular organization and broader topography. At over 4 cm long, more than 400 transverse histological sections, each 50 µm thick, would need to be cut to visualize just the proximal half of a mouse’s spinal cord. With a width of only ~2-3 mm these sections take skill to collect, handle, orient, and mount properly, with lost sections meaning lost information and an incomplete picture come imaging time. Upon acquisition of a complete set of whole-section images, registering them to one another to digitally reconstruct even a short length of the spinal cord can present a sizable challenge, with tracing of blood vessels, neuronal axons, and other radially-aligned structures of interest being even more difficult.
Enter modern tissue clearing, the approach of electrophoretically removing samples’ lipid-filled, light-scattering cell membranes and then rendering them optically transparent via incubation in aqueous solutions that raise and homogenize their refractive index. These cleared samples, such as the one provided by Prof. Helen Lai of UT Southwestern that is shown in the video, can then be imaged intact and without the need for sectioning, mounting, serial imaging, and registration. Thanks to an initial preservation step in which the sample was equilibrated in an epoxy-containing solution called SHIELD and then chemically cured to provide an extra layer of intermolecular crosslinking, fluorescence of the sample’s tdTomato molecules remained robust even after clearing. The bird’s-eye view that intact-sample approaches provide enable researchers to examine morphology without interruption, more easily detect the distribution & periodicity of rare cell-types and measure these properties accurately, and count & quantify each cell reliably as there is no ambiguity arising from cell bodies split across sections. Further, with LifeCanvas’s own SmartSPIM light-sheet microscope entire samples can be imaged rapidly, making it practical to avoid sampling-based stereological analysis methods that are tedious to employ and that have limitations in their applicability and interpretability.
Using histological techniques to visualize the distribution of phosphorylated tau protein, a hallmark of Alzheimer’s disease, can help researchers better understand disease mechanisms and assess the level of pathology in post-mortem tissue. LifeCanvas’s methods and technologies are fully compatible with human tissue samples, thus providing an unparalleled window into human clinical specimen analysis and disease diagnosis.
Phospho-tau labeling of human frontal cortex tissue isolated post-mortem from a clinical patient with advanced Alzheimer’s disease demonstrates widespread labeling of this pathological hallmark. Tissue courtesy of Kymry Jones and Prof. Carol Miller, USC.
Vasculature damage is a hallmark of many pathological conditions and is of particular interest to researchers studying stroke. However, vascular networks are difficult to study in fine detail at a regional or whole- organ level. By utilizing a dye-based approach that is compatible with LifeCanvas’s clearing device, researchers can achieve rapid high-resolution imaging of organ-scale tissues.
Intravenously-delivered fluorescent dye labeling of an extensive network of mouse brain blood vessels, imaged at high resolution with fine detail.
Image courtesy of Profs. David Kleinfeld and Byungkook Lim, UCSD.
Founded by CLARITY (Nature, 2013), SWITCH (Cell, 2015), and SHIELD (Nature Biotechnology, 2019) inventors from MIT and located in Cambridge, MA, LifeCanvas Technologies develops and offers as services a full suite of research tools for tissue clearing, labeling, and volumetric imaging of intact organs such as the brain. We are excited to show the biomedical research community the power of our whole-sample analysis methods, which provide greater value and richer information content versus traditional thin-section techniques, all at a competitive price.
© Copyright LifeCanvas Technologies 2019. All Rights Reserved